CN103911240A - Grape wine - Google Patents

Grape wine Download PDF

Info

Publication number
CN103911240A
CN103911240A CN201410170763.0A CN201410170763A CN103911240A CN 103911240 A CN103911240 A CN 103911240A CN 201410170763 A CN201410170763 A CN 201410170763A CN 103911240 A CN103911240 A CN 103911240A
Authority
CN
China
Prior art keywords
grape wine
parts
chinese medicine
medicine powder
herba lycopodii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410170763.0A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANG CHAOFANG
Original Assignee
JIANG CHAOFANG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANG CHAOFANG filed Critical JIANG CHAOFANG
Priority to CN201410170763.0A priority Critical patent/CN103911240A/en
Publication of CN103911240A publication Critical patent/CN103911240A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a grape wine, and relates to a healthcare grape wine capable of preventing high blood glucose. The healthcare grape wine capable of preventing high blood glucose, provided by the invention, is characterized by comprising the following raw materials, lycopodium clavatum traditional Chinese medicine powder and grape wine, wherein the proportion of the lycopodium clavatum traditional Chinese medicine powder and the grape wine is 20-200g/L, and the lycopodium clavatum traditional Chinese medicine powder is prepared from the following raw materials in parts by weight: 10-20 parts of lycopodium clavatum, 8-20 parts of plumeria rubra, 3-10 parts of liquorice, 5-10 parts of semen cuscutae, 10-20 parts of tuckahoe and 5-10 parts of dwarf lilyturf root. The grape wine has the advantages that the plumeria rubra, the semen cuscutae, the tuckahoe, the dwarf lilyturf root and juncus roemerianus are used for conditioning the balance of five internal organs, namely heart, liver, spleen, lung and kidney of a human body, dispersing blood stasis, clearing turbid qi and quenching thirst, the lycopodium clavatum is used for relaxing the muscles, stimulating the blood circulation, reinforcing qi and dredging collaterals, so that the purpose of decreasing blood sugar is achieved, the appropriate alcohol power of the grape wine is used for promoting the effect of blood sugar decreasing, and the grape wine is suitable for patients with high blood sugar and diabetes.

Description

A kind of grape wine
Technical field
The present invention relates to a kind of health wine, especially a kind of health wine of preventing and treating hyperglycemia.
Background technology
The mankind's healthy living, closely related with stablizing of external environment (as air, water source) and interior environment (as blood, tissue juice).The too high interior environment that has destroyed just human body of blood sugar, cause a series of biochemical pathological changes, affect the function of each internal organs, long-term hyperglycemia can make each histoorgan generation pathology of whole body, cause the generation of acute and chronic complication, as pancreas function exhaustion, dehydration, electrolyte disturbance, nutritive deficiency, resistibility decline, impaired renal function, DPN, ocular fundus pathology etc., therefore prevent and to treat hyperglycemia very important.
Prior art is not applied Herba Lycopodii and is prevented and treated hyperglycemia, does not apply Herba Lycopodii preparation yet and prevents and treats the health wine of hyperglycemia, and the single and nourishing function of taste has its limitation.As the invention that is 200710056888.0 at the number of patent application of Chinese patent information center announcement---regulate blood sugar health preserving wine and preparation method thereof, this disclosure of the invention a kind of adjusting blood sugar health preserving wine, comprise white wine and puerarin, astragalus polysaccharides, jasminoidin, one or more in ursolic acid, the health factor of maximum saturation solubleness containing from 1mg to white wine in every 500ml wine, its beneficial effect is: blood sugar reducing health wine has retained colourless or micro-yellow of original white wine, thoroughly clear, free from extraneous odour, there is the sweet-smelling of wine, health factor contained in wine is clear and definite, stable and controllable for quality, the health factor adding, containing any chemical additive, is not green food and the healthcare products of environment-friendly type, and the content of active Chinese drug component material wherein has the effect that suppresses or prevent hyperglycemia.
Summary of the invention
In order to solve prior art problem, the object of the invention is to provide a kind of health wine of preventing and treating hyperglycemia.
Technical scheme: a kind of health wine of preventing and treating hyperglycemia, is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10.
Preparation method: Herba Lycopodii Chinese medicine powder is added in grape wine in proportion, after mixing, then be finished product through sterilizing, filtration, encapsulation.
As optimization, a kind of health wine of preventing and treating hyperglycemia of the present invention, is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, and both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10, Rush 3-5, dark plum 3-10.
Herba Lycopodii, toil temperature, expelling wind and cold, dehumidifying are subsided a swelling, are stimulated the circulation of the blood and cause the muscles and joints to relax." Hunan medicine will " records Herba Lycopodii: sweet, flat.Nontoxic, enter the heart, kidney two warps, relax the muscles and stimulate the blood circulation, invigorating qi and dredging collateral.
Flower of Mexican Frangipani, cool in nature, taste is sweet, light; Return large intestine, stomach warp, there is effect of moistening lung removing toxic substances, clearing heat and expelling damp, laxation.
Radix Glycyrrhizae taste is sweet, flat.The thoughts of returning home, lung, spleen, stomach warp.Function cures mainly: invigorates the spleen and benefits qi, and clearing heat and detoxicating, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and the stomach, fatigue and weakness, shortness of breath and palpitation, coughing with a lot of sputum, gastral cavity abdomen, the anxious pain of four limbs contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
South Dodder Seed Chinese Dodder Seed acrid-sweet flavor, property is flat, enters liver, kidney two warps.There is tonifying kidney and benefiting sperm, nourish the liver to improve visual acuity, antiabortive effect.
Poria cocos taste is sweet, light, property is flat, be used as medicine there is promoting diuresis to eliminate damp pathogen, the function of beneficial spleen and stomach, tranquillizing by calming the heart.Modern medicine study: Poria cocos energy enhancing body immunologic function, Pachymose has significantly antitumor and protect the liver dirty effect.
Radix Ophiopogonis, the micro-sugariness hardship of property, cold, there is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, reinforcing yin essence benefit essence, five viscera settling effect.
Medulla Junci, is slightly cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Urinary bladder channel.Effect: relieving stranguria by diuresis; Clearing heart fire.Dark plum acid, puckery, flat, returns liver, spleen, lung, large intestine channel.[function cures mainly] astringes the lung, and puckery intestines, promote the production of body fluid, claming ascaris.For chronic cough of deficiency lung, protracted dysentery laxation, abnormal heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract (" Chinese Pharmacopoeia ").
The traditional Chinese medical science thinks, diabetes are mainly that the five internal organs are weak due to the plain body deficiency of Yin, multiple because of eating and drinking without temperance, overfeeding delicious food, and disorder of emotion, labor is wanted excessively, and causes deficiency of kidney-YIN, and lung stomach is scorching; Interpretation of the cause, onset and process of an illness emphasis is that the deficiency of Yin is scorching, and take the deficiency of Yin as this, scorching is mark; With the passing of time disease prolongs, deficiency of YIN affecting YANG, deficiency in both YIN and YANG; The deficiency of Yin is scorching, and the bright liquid in consumption Tianjin makes blood viscous, the not smooth stasis of blood that forms of blood; Deficiency of YIN affecting YANG, the deficiency of yang is cold solidifying, also can cause sun in hemostasis.
Advantage of the present invention: 1, Herba Lycopodii Xin Wenyi impairment of yin blood of the present invention, therefore adapted Flower of Mexican Frangipani, Radix Glycyrrhizae are in harmonious proportion, make its institute partially, its taste is glycol, fresh and sweet, has channels sootheing and network vessel quickening, function of promoting blood circulation to disperse blood clots.
2, South Dodder Seed Chinese Dodder Seed tonifying kidney and benefiting sperm, Poria cocos promoting diuresis to eliminate damp pathogen, beneficial spleen and stomach, Radix Ophiopogonis is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, and Medulla Junci clearing heart fire, dark plum are quenched one's thirst and are brought down a fever, and more contribute to promoting blood circulation and removing blood stasis hypoglycemic.
3, the present invention is by the balance of Flower of Mexican Frangipani, South Dodder Seed Chinese Dodder Seed, Poria cocos, Radix Ophiopogonis, Medulla Junci conditioning human body-centered liver spleen lung kidney the five internal organs, stagnation resolvation is pure and impure quenches one's thirst, relax the muscles and stimulate the blood circulation with Herba Lycopodii again, thereby invigorating qi and dredging collateral reaches hypoglycemic object, relend making every effort to promote into blood sugar decreasing effect of grape wine appropriateness alcohol, be applicable to the patient such as hyperglycemia, diabetes.
4, the present invention has significant hypoglycemic activity to suprarenin hyperglycemia mouse and tetraoxypyrimidine hyperglycemia mouse.Each 20 of male and female mice is selected in experiment; Adopt respectively suprarenin and tetraoxypyrimidine to set up hyperglycemia mouse model, then give Chinese medicine powder of the present invention, U26452, phenformin and treat and survey glucose level.In the hyperglycemia mouse of bringing out at suprarenin, the present invention can make fasting serum glucose [(16. 58 ± 3. 92) mmol/L] be reduced to (7. 56 ± 2. 63) mmol/L, effect and U26452 comparison, no significant difference (P>0.05); In the hyperglycemia mouse of model induced by alloxan, the present invention is reduced to fasting serum glucose [(15. 56 ± 1. 83) mmol/L] (7. 55 ± 1.65) mmol/L, blood sugar reducing function is significantly better than phenformin (P<0 05), and causes hypoglycemic side effect without U26452.Conclusion: the present invention can significantly reduce the glucose level (P <0. 001) of 2 kinds of modeling animals, and makes blood sugar be down to normal level.
5, the present invention shows through more than the 60 routine sugared dung patients' that make a definite diagnosis clinical observation on the therapeutic effect, and the present invention has remarkable reduction glycosuria patient's glucose level, makes blood sugar recovery normal.
Clinical observation result of the present invention:
1.1 physical data: select the People's Hospital of city outpatient service diabetes B patient 60 examples, be divided at random two groups.Treatment group 30 examples, male 16 examples, female's 14 examples, 30~70 years old age, average (50 ± 1.5) year, the course of disease 6 months~15 years, average (8.0 ± 1.2) year; Control group 30 examples, male 18 examples, female's 12 examples, 29~70 years old age.Two groups of physical data comparing difference not statistically significants (P>0.05), have comparability.
1.2 case selections: with reference to the World Health Organization's (WHO) diabetes diagnosis in 1999 and somatotype standard [1]: diabetic symptom+random time plasma glucose levels >=11.1mmol/L(200mg/dl).The patient's random packet that meets above-mentioned standard is carried out to observational study, and the patient that part takes traditional Chinese medicine stops former Chinese medicine and includes observation in after 2 weeks, and the patient's to be directly brought into not taking traditional Chinese medicine is observed.Two groups of patients all give diabetes Primary Care, comprise dietary control, kinesitherapy and orally-taken blood sugar reducing Western medicine, and hypoglycemic Western medicine adopts N1,N1-Dimethylbiguanide, carries out drug usage and dose adjustment according to blood sugar situation.
1.3 methods for the treatment of: treatment group is taken Chinese medicine powder of the present invention on the basis of taking N1,N1-Dimethylbiguanide.Basic side is made up of the composition of raw materials of following weight part: Herba Lycopodii 10, Flower of Mexican Frangipani 10, Radix Glycyrrhizae 3, South Dodder Seed Chinese Dodder Seed 5, Poria cocos 10, Radix Ophiopogonis 5; Every natural gift are taken for three times, each 4 grams.Control group routine is taken N1,N1-Dimethylbiguanide.Two groups are consistent in dietary control, kinesitherapy, and be 2 months two groups of courses for the treatment of.
1.4 observation index: measure respectively fasting plasma glucose (FPG), postprandial blood sugar (2hBG), glycolated hemoglobin (HbA1c), fasting insulin (FINS), blood fat (TC, TG, HDL-C, LDL-C) before and after treatment, blood sugar determination of glucose oxidase, Regular Insulin is measured with putting the method for exempting from, blood fat is measured with automatic clinical chemistry analyzer, HOMA-IR employing Haffner etc. [3,4] in Homa model, calculate the formula of IR, be HOMA-IR=FPG × FINS/22.5 (FPG unit is mmol/L, and FINS unit is mU/L).
1.5 statistical methods: adopt SPSS 14.0 statistical analysis softwares to carry out statistical procedures.Measurement data adopts t check, enumeration data χ2-test,chi-square test.
2 results: before and after two groups of treatments, the variation of FPG, 2hBG, HbAIc, FINS and HOMA-IR refers to table 1.By in table 1, we can see, treat front two groups of patient FPG, 2hBG, HbAlc, FINS, the horizontal comparing difference not statistically significant of HOMA-IR (P>0.05); After treating, two groups of FPG, 2hBG, HbAlc, FINS, HOMA-IR levels have statistical significance (P<0.05 or P<0.01) with the front comparing differences for the treatment of, before treatment group patient's These parameters and treatment, relatively have significant difference (P<0.01).Prompting treatment group and control group all can reduce diabetes blood sugar, but it is more obvious to improve blood sugar with treatment group.
The variation of FPG, 2hBG, HbAlc, FINS and HOMA-IR before and after table 1 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; The rear two groups of FINS for the treatment of and HOMA-IR compare ^P<0.05, ^^P<0.01.
Before and after two groups of patient treatments, the variation of TC, TG, HDL-C, LDL-C is in table 2.From table 2, we can see the front two groups of patients' for the treatment of the horizontal comparing difference not statistically significant of TC, TG, HDL-C, LDL-C (P>0.05); After treatment, TC, TG, HDL-C, the LDL-C level of two groups have considerable change, wherein TC, TG, LDL-C level have statistical significance (P<0.05) with the front comparing difference for the treatment of, and relatively have significant difference (P<0.01) before treatment group HDL-C level and treatment.Illustrate that treatment group and control group all can improve diabetic subject's blood lipid level, and more remarkable with treatment group effect.
The variation of TC, TG, HDL-C, the horizontal content of LDL-C before and after table 2 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; After treatment, two groups of indices are compared ^P<0.05, ^^P<0.01.
Embodiment
Embodiment 1: a kind of health wine of preventing and treating hyperglycemia, is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10.
Preparation method: Herba Lycopodii Chinese medicine powder is added in grape wine in proportion, after mixing, then be finished product through sterilizing, filtration, encapsulation.
Embodiment 2: a kind of health wine of preventing and treating hyperglycemia, is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10, Rush 3-5, dark plum 3-10.
Preparation method is with embodiment 1.

Claims (2)

1. prevent and treat a health wine for hyperglycemia, it is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10.
2. prevent and treat a health wine for hyperglycemia, it is characterized in that comprising following raw material: Herba Lycopodii Chinese medicine powder and grape wine, both proportionings are 20-200g/L; Described Herba Lycopodii Chinese medicine powder is made up of the composition of raw materials of following weight part: Herba Lycopodii 10-20, Flower of Mexican Frangipani 8-20, Radix Glycyrrhizae 3-10, South Dodder Seed Chinese Dodder Seed 5-10, Poria cocos 10-20, Radix Ophiopogonis 5-10, Rush 3-5, dark plum 3-10.
CN201410170763.0A 2014-04-27 2014-04-27 Grape wine Pending CN103911240A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410170763.0A CN103911240A (en) 2014-04-27 2014-04-27 Grape wine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410170763.0A CN103911240A (en) 2014-04-27 2014-04-27 Grape wine

Publications (1)

Publication Number Publication Date
CN103911240A true CN103911240A (en) 2014-07-09

Family

ID=51037249

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410170763.0A Pending CN103911240A (en) 2014-04-27 2014-04-27 Grape wine

Country Status (1)

Country Link
CN (1) CN103911240A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102936547A (en) * 2012-11-29 2013-02-20 蒋朝芳 Healthcare port wine
CN103305380A (en) * 2013-06-22 2013-09-18 河南歌瑞农牧股份有限公司 Health care grape wine
CN103509689A (en) * 2012-06-27 2014-01-15 如皋市娟志服装厂 Common clubmoss herb blood-circulation-promoting wine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103509689A (en) * 2012-06-27 2014-01-15 如皋市娟志服装厂 Common clubmoss herb blood-circulation-promoting wine
CN102936547A (en) * 2012-11-29 2013-02-20 蒋朝芳 Healthcare port wine
CN103305380A (en) * 2013-06-22 2013-09-18 河南歌瑞农牧股份有限公司 Health care grape wine

Similar Documents

Publication Publication Date Title
CN103194360A (en) Medicinal liquor with healthcare function as well as preparation method and application thereof
CN103919022A (en) Health-care steamed buns for preventing and treating hyperglycemia
CN103907957A (en) Bamboo rat sausage
CN103919176A (en) Lobster meat sausage
CN103947925A (en) Buckwheat porridge
CN103919153A (en) Healthcare quail sausage
CN103947916A (en) Jelly
CN103911266A (en) Yellow wine
CN103907970A (en) Whitebait meat balls
CN102258715A (en) Honeysuckle wine
CN103911267A (en) White spirit
CN103931772A (en) Milk tea
CN103919175A (en) Prawn sausage
CN103932226A (en) Venison sausage
CN103919162A (en) Mutton sausage
CN103907963A (en) Crocodile meat sausage
CN103911240A (en) Grape wine
CN103919155A (en) Healthcare pigeon sausage
CN103918740A (en) Premixed powder for preventing and treating hyperglycemia
CN103911238A (en) Beer
CN103907661A (en) Health care biscuit capable of preventing hyperglycemia
CN103907956A (en) Health horsemeat sausage
CN103919161A (en) Healthcare pork sausage
CN103907969A (en) Reeves shad meat ball
CN103931999A (en) Beef sausage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140709